Testing effectiveness (Phase 2)Ended earlyNCT04458298
What this trial is testing
Evaluate OP-101 (Dendrimer N-acetyl-cysteine) in Severe Coronavirus Disease 2019 (COVID-19) Patients
Who this might be right for
COVID-19
Ashvattha Therapeutics, Inc. 28